Purified anti-Serpin A12 Antibody, Serpin A12, A16088B,BioLegend,624651

For immunohistochemistry, Citrate buffer, 10X (Cat. No. 420902) or Tris-EDTA pH 9.0 is recommended.

Host

Mouse

Reactivity

Human, Mouse

Application

IHC-P - Quality testedWB - Verified

Platform ID

BAB423531074

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NamePurified anti-Serpin A12 Antibody, Serpin A12, A16088B
Cat. No.624651
HostMouse
RRIDAB_3083413 (BioLegend Cat. No. 624651)AB_3083413 (BioLegend Cat. No. 624652)
IsotypeMouse IgG2b, κ
ReactivityHuman, Mouse
ApplicationIHC-P - Quality testedWB - Verified
ClonalityMonoclonal
Clone NumberA16088B
Concentration0.5 mg/mL
TargetSerpin A12
ImmunogenRecombinant fragment of human Serpin A12
PurityThe antibody was purified by affinity chromatography.
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide
StorageThe antibody solution should be stored undiluted between 2°C and 8°C.
Regulatory StatusResearch Use Only

Scientific Background

Human Serpin A12, also known as Vaspin, is a secreted adipokine that is found in visceral adipose tissue. It belongs to the serpin superfamily, class A. It's known protease target is KLK7, a member of the kallikrein family. In humans, Serpin A12 expression may increase at the onset of diabetes and decrease when the disease aggravates. The administration of recombinant Serpin A12 in a diet-induced mouse obesity model suggests that it may represent an insulin-sensitizing adipokine. Low serum concentration of Serpin A12 may be a risk factor for the progression of type-2 diabetes mellitus. Although its mechanism of action is not fully understood, KLK7 inhibition seems to be the most likely underlying physiological mechanism for the compensatory effects on obesity-induced insulin resistance. In addition to its relation to diabetes, Serpin A12 exerts protective effects on heart disease. Its low concentrations correlate with coronary artery diseases’ severity and unstable angina pectoris. Serpin A12 may inhibit endothelial cell apoptosis, attenuate high glucose stimulated vascular smooth muscle cell proliferation, and chemokinesis. It also acts as a ligand for the cell surface GRP78/voltage dependent anion channel complex in endothelial cells and promotes proliferation, inhibits apoptosis, and protects against diabetes mellitus associated vascular injuries.

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.